Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])-Reference-Cited by-同舟云学术

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])

Published:2016-04-14 Issue:9 Volume:24 Page:3847-3855
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Sio Terence T.,Atherton Pamela J.,Birckhead Brandon J.,Schwartz David J.,Sloan Jeff A.,Seisler Drew K.,Martenson James A.,Loprinzi Charles L.,Griffin Patricia C.,Morton Roscoe F.,Anders Jon C.,Stoffel Thomas J.,Haselow Robert E.,Mowat Rex B.,Wittich Michelle A. Neben,Bearden James D.,Miller Robert C.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-016-3213-3.pdf

Reference36 articles.

1. McQuestion M (2011) Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 27(2):009

2. Sharp L, Johansson H, Landin Y, et al. (2011) Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments—a pilot study. Eur J Cancer 47(18):2665–2672

3. Gosselin TK, Schneider SM, Plambeck MA, et al. (2010) A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy. Oncol Nurs Forum 37(5):619–626